Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:56 UTC |
---|
HMDB ID | HMDB0015309 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Chlormezanone |
---|
Description | Chlormezanone is only found in individuals that have used or taken this drug. It is a non-benzodiazepine that is used in the management of anxiety. It has been suggested for use in the treatment of muscle spasm. [PubChem]Chlormezanone binds to central benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways. |
---|
Structure | CN1C(C2=CC=C(Cl)C=C2)S(=O)(=O)CCC1=O InChI=1S/C11H12ClNO3S/c1-13-10(14)6-7-17(15,16)11(13)8-2-4-9(12)5-3-8/h2-5,11H,6-7H2,1H3 |
---|
Synonyms | Value | Source |
---|
(+-)-Chlormezanone | ChEBI | 2-(p-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide | ChEBI | 2-(p-Chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-on-1,1-dioxide | ChEBI | Chlormethazanone | ChEBI | Chlormezanona | ChEBI | Chlormezanonum | ChEBI | Trancopal | Kegg | Chlormethazone | HMDB | Chlormezanon | HMDB | Clormetazanone | HMDB | Clormetazon | HMDB | Clormezanone | HMDB | Dichloromethazanone | HMDB | Dichloromezanone | HMDB | DL-Chlormezanone | HMDB |
|
---|
Chemical Formula | C11H12ClNO3S |
---|
Average Molecular Weight | 273.736 |
---|
Monoisotopic Molecular Weight | 273.022641652 |
---|
IUPAC Name | 2-(4-chlorophenyl)-3-methyl-1lambda6,3-thiazinane-1,1,4-trione |
---|
Traditional Name | 2-(4-chlorophenyl)-3-methyl-1lambda6,3-thiazinane-1,1,4-trione |
---|
CAS Registry Number | 80-77-3 |
---|
SMILES | CN1C(C2=CC=C(Cl)C=C2)S(=O)(=O)CCC1=O |
---|
InChI Identifier | InChI=1S/C11H12ClNO3S/c1-13-10(14)6-7-17(15,16)11(13)8-2-4-9(12)5-3-8/h2-5,11H,6-7H2,1H3 |
---|
InChI Key | WEQAYVWKMWHEJO-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as chlorobenzenes. Chlorobenzenes are compounds containing one or more chlorine atoms attached to a benzene moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Halobenzenes |
---|
Direct Parent | Chlorobenzenes |
---|
Alternative Parents | |
---|
Substituents | - Chlorobenzene
- Aryl chloride
- Aryl halide
- 1,3-thiazinane
- Sulfone
- Tertiary carboxylic acid amide
- Carboxamide group
- Lactam
- Carboxylic acid derivative
- Azacycle
- Organoheterocyclic compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Carbonyl group
- Organooxygen compound
- Organic nitrogen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 116.2 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 1.61 g/L | Not Available | LogP | 1.3 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Chlormezanone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0fi0-3900000000-5e5d0d06b736cd6e312d | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Chlormezanone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-0udi-7900000000-6c729f1a3c9cb4241b45 | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlormezanone LC-ESI-qTof , Positive-QTOF | splash10-0kmi-0690000000-1392c5b54088e4de1cda | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlormezanone , positive-QTOF | splash10-0kmi-0690000000-1392c5b54088e4de1cda | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlormezanone 45V, Positive-QTOF | splash10-00e9-9800000000-6a7c54ed417bbe3bf39c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlormezanone 15V, Negative-QTOF | splash10-0a59-0980000000-f53a3c2f328bf92ecea2 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlormezanone 30V, Negative-QTOF | splash10-001i-3920000000-72d4eeb6dec00afcf714 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlormezanone 60V, Negative-QTOF | splash10-00di-9000000000-6d971fd886764cbe9edc | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlormezanone 45V, Negative-QTOF | splash10-00e9-9800000000-160e4ad7fa10bdfbce0e | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlormezanone 10V, Positive-QTOF | splash10-00di-1390000000-8bee31987cb996a6941d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlormezanone 20V, Positive-QTOF | splash10-00di-3290000000-fe5427b04dacecf713b8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlormezanone 40V, Positive-QTOF | splash10-0006-8900000000-d26b01b91b77c8ccf5ff | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlormezanone 10V, Negative-QTOF | splash10-00di-0290000000-13d72ad524b7d05b5dd4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlormezanone 20V, Negative-QTOF | splash10-0udi-1920000000-f5d97bfa6c8356b4baf4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlormezanone 40V, Negative-QTOF | splash10-0a4r-7900000000-66d56cc398b6ac3900a0 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlormezanone 10V, Positive-QTOF | splash10-00di-0090000000-fd587e06fea093c00217 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlormezanone 20V, Positive-QTOF | splash10-0ufr-0910000000-d1589364a7086eeb574d | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlormezanone 40V, Positive-QTOF | splash10-0uxr-2900000000-941a0471defcde1f16b6 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlormezanone 10V, Negative-QTOF | splash10-00di-0090000000-0ebbdf325da9547d6d6a | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlormezanone 20V, Negative-QTOF | splash10-03k9-1390000000-fb20b8fdbf901e9ead65 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlormezanone 40V, Negative-QTOF | splash10-01q9-9160000000-435ff6a491b5b8c51796 | 2021-10-11 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01178 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01178 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 uM | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities | Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB01178 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 2616 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Chlormezanone |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 2717 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 3619 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Gautier V, Vincon G, Demotes-Mainard F, Albin H: [Pharmacokinetics of chlormezanone in healthy volunteers]. Therapie. 1990 Jul-Aug;45(4):315-9. [PubMed:2399514 ]
- Oelschlager H, Klinger W, Rothley D, Seeling A, Bockhard H, Hofmann B, Machts H, Riederer H, Rackur H: [Cleavage and biotransformation of the central muscle relaxant chlormezanone]. Pharmazie. 1998 Sep;53(9):620-4. [PubMed:9770210 ]
- Seeling A, Oelschlager H, Rothley D: [Important pharmaceutical-chemical characteristics of the central muscle relaxant chlormezanone]. Pharmazie. 2000 Apr;55(4):293-6. [PubMed:10798243 ]
- Wollina U, Hipler UC, Seeling A, Oelschlager H: Investigations of interactions of chlormezanone racemate and its enantiomers on human keratinocytes and human leucoytes in vitro. Skin Pharmacol Physiol. 2005 May-Jun;18(3):132-8. [PubMed:15897685 ]
|
---|